☰

Ching-Tai Huang, Ph.D. - Publications

Affiliations: 
2001 Johns Hopkins University, Baltimore, MD 
Area:
Immunology
Tree Info Grants Similar researchers PubMed Report error

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Yu H, Nishio H, Barbi J, Mitchell-Flack M, Vignali PDA, Zheng Y, Lebid A, Chang KY, Fu J, Higgins M, Huang CT, Zhang X, Li Z, Blosser L, Tam A, et al. Neurotrophic factor Neuritin modulates T cell electrical and metabolic state for the balance of tolerance and immunity. Biorxiv : the Preprint Server For Biology. PMID 38352414 DOI: 10.1101/2024.01.31.578284  0.563
2023 Dutta A, Hung CY, Chen TC, Hsiao SH, Chang CS, Lin YC, Lin CY, Huang CT. An IL-17-EGFR-TRAF4 axis contributes to the alleviation of lung inflammation in severe influenza. Communications Biology. 6: 600. PMID 37270623 DOI: 10.1038/s42003-023-04982-0  0.411
2023 Lin YC, Wu CH, Chen PJ, Huang CH, Yang CK, Dutta A, Huang CT, Lin CY. Murine cytotoxic CD4+ T cells in the tumor microenvironment are at a hyper-maturation stage of Th1 CD4+ T cells sustained by IL-12. International Immunology. PMID 37202206 DOI: 10.1093/intimm/dxad015  0.606
2018 Lin YC, Hsu CY, Huang SK, Fan YH, Huang CH, Yang CK, Su WT, Chang PC, Dutta A, Liu YJ, Huang CT, Chen TC, Lin CY. Induction of liver-specific intrahepatic myeloid cells aggregation expands CD8 T cell and inhibits growth of murine hepatoma. Oncoimmunology. 7: e1502129. PMID 30524897 DOI: 10.1080/2162402X.2018.1502129  0.415
2015 Kang CW, Dutta A, Chang LY, Mahalingam J, Lin YC, Chiang JM, Hsu CY, Huang CT, Su WT, Chu YY, Lin CY. Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer. Scientific Reports. 5: 15659. PMID 26493689 DOI: 10.1038/srep15659  0.504
2015 Chang LY, Lin YC, Chiang JM, Mahalingam J, Su SH, Huang CT, Chen WT, Huang CH, Jeng WJ, Chen YC, Lin SM, Sheen IS, Lin CY. Blockade of TNF-α signaling benefits cancer therapy by suppressing effector regulatory T cell expansion. Oncoimmunology. 4: e1040215. PMID 26451304 DOI: 10.1080/2162402X.2015.1040215  0.449
2015 Dutta A, Huang CT, Chen TC, Lin CY, Chiu CH, Lin YC, Chang CS, He YC. IL-10 inhibits neuraminidase-activated TGF-β and facilitates Th1 phenotype during early phase of infection. Nature Communications. 6: 6374. PMID 25728041 DOI: 10.1038/ncomms7374  0.517
2014 Mahalingam J, Lin CY, Chiang JM, Su PJ, Chu YY, Lai HY, Fang JH, Huang CT, Lin YC. CD4⁺ T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancer. Plos One. 9: e108554. PMID 25268580 DOI: 10.1371/journal.pone.0108554  0.332
2013 Dutta A, Miaw SC, Yu JS, Chen TC, Lin CY, Lin YC, Chang CS, He YC, Chuang SH, Yen MI, Huang CT. Altered T-bet dominance in IFN-γ-decoupled CD4+ T cells with attenuated cytokine storm and preserved memory in influenza. Journal of Immunology (Baltimore, Md. : 1950). 190: 4205-14. PMID 23509355 DOI: 10.4049/jimmunol.1202434  0.565
2013 Lin YC, Mahalingam J, Chiang JM, Su PJ, Chu YY, Lai HY, Fang JH, Huang CT, Chiu CT, Lin CY. Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer. International Journal of Cancer. Journal International Du Cancer. 132: 1341-50. PMID 22907255 DOI: 10.1002/ijc.27784  0.489
2012 Mahalingam J, Lin YC, Chiang JM, Su PJ, Fang JH, Chu YY, Huang CT, Chiu CT, Lin CY. LAP+CD4+ T cells are suppressors accumulated in the tumor sites and associated with the progression of colorectal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5224-33. PMID 22879386 DOI: 10.1158/1078-0432.CCR-12-0211  0.493
2012 Chang LY, Lin YC, Kang CW, Hsu CY, Chu YY, Huang CT, Day YJ, Chen TC, Yeh CT, Lin CY. The indispensable role of CCR5 for in vivo suppressor function of tumor-derived CD103+ effector/memory regulatory T cells. Journal of Immunology (Baltimore, Md. : 1950). 189: 567-74. PMID 22664873 DOI: 10.4049/jimmunol.1200266  0.491
2012 Chang LY, Lin YC, Mahalingam J, Huang CT, Chen TW, Kang CW, Peng HM, Chu YY, Chiang JM, Dutta A, Day YJ, Chen TC, Yeh CT, Lin CY. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells. Cancer Research. 72: 1092-102. PMID 22282655 DOI: 10.1158/0008-5472.CAN-11-2493  0.545
2009 Yen HR, Harris TJ, Wada S, Grosso JF, Getnet D, Goldberg MV, Liang KL, Bruno TC, Pyle KJ, Chan SL, Anders RA, Trimble CL, Adler AJ, Lin TY, Pardoll DM, ... Huang CT, et al. Tc17 CD8 T cells: functional plasticity and subset diversity. Journal of Immunology (Baltimore, Md. : 1950). 183: 7161-8. PMID 19917680 DOI: 10.4049/Jimmunol.0900368  0.474
2009 Lin YC, Chang LY, Huang CT, Peng HM, Dutta A, Chen TC, Yeh CT, Lin CY. Effector/memory but not naive regulatory T cells are responsible for the loss of concomitant tumor immunity. Journal of Immunology (Baltimore, Md. : 1950). 182: 6095-104. PMID 19414761 DOI: 10.4049/jimmunol.0803829  0.376
2008 Zarek PE, Huang CT, Lutz ER, Kowalski J, Horton MR, Linden J, Drake CG, Powell JD. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood. 111: 251-9. PMID 17909080 DOI: 10.1182/Blood-2007-03-081646  0.357
2007 Tsai IF, Lin CY, Huang CT, Lin YC, Yang CM, Lin YC, Liao CH. Modulation of human monocyte-derived dendritic cells maturation by a soluble guanylate cyclase activator, YC-1, in a cyclic nucleotide independent manner. International Immunopharmacology. 7: 1299-310. PMID 17673145 DOI: 10.1016/j.intimp.2007.05.010  0.463
2006 Lin CT, Chang TC, Shaw SW, Cheng PJ, Huang CT, Chao A, Soong YK, Lai CH. Maintenance of CD8 effector T cells by CD4 helper T cells eradicates growing tumors and promotes long-term tumor immunity. Vaccine. 24: 6199-207. PMID 16824651 DOI: 10.1016/j.vaccine.2006.05.108  0.485
2005 Safford M, Collins S, Lutz MA, Allen A, Huang CT, Kowalski J, Blackford A, Horton MR, Drake C, Schwartz RH, Powell JD. Egr-2 and Egr-3 are negative regulators of T cell activation. Nature Immunology. 6: 472-80. PMID 15834410 DOI: 10.1038/ni1193  0.463
2005 Drake CG, Doody AD, Mihalyo MA, Huang CT, Kelleher E, Ravi S, Hipkiss EL, Flies DB, Kennedy EP, Long M, McGary PW, Coryell L, Nelson WG, Pardoll DM, Adler AJ. Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen. Cancer Cell. 7: 239-49. PMID 15766662 DOI: 10.1016/j.ccr.2005.01.027  0.417
2005 Safford M, Collins S, Lutz MA, Allen A, Huang C, Kowalski J, Blackford A, Horton MR, Drake C, Schwartz RH, Powell JD. Erratum: Egr-2 and Egr-3 are negative regulators of T cell activation Nature Immunology. 6: 737-737. DOI: 10.1038/NI0705-737  0.43
2004 Huang CT, Workman CJ, Flies D, Pan X, Marson AL, Zhou G, Hipkiss EL, Ravi S, Kowalski J, Levitsky HI, Powell JD, Pardoll DM, Drake CG, Vignali DA. Role of LAG-3 in regulatory T cells. Immunity. 21: 503-13. PMID 15485628 DOI: 10.1016/J.Immuni.2004.08.010  0.688
2004 Yang Y, Huang CT, Huang X, Pardoll DM. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nature Immunology. 5: 508-15. PMID 15064759 DOI: 10.1038/Ni1059  0.67
2004 Lin C, Huang C, Chang T, Lai C, Soong Y. CD4 Helper T Cells Maintain CD8 Effector T Cells To Eradicate Growing Tumor and Promote Long-Term Tumor Immunity Journal of Immunotherapy. 27: S50-S51. DOI: 10.1097/00002371-200411000-00183  0.516
2003 Hamad AR, Mohamood AS, Trujillo CJ, Huang CT, Yuan E, Schneck JP. B220+ double-negative T cells suppress polyclonal T cell activation by a Fas-independent mechanism that involves inhibition of IL-2 production. Journal of Immunology (Baltimore, Md. : 1950). 171: 2421-6. PMID 12928389 DOI: 10.4049/Jimmunol.171.5.2421  0.604
2003 Huang CT, Huso DL, Lu Z, Wang T, Zhou G, Kennedy EP, Drake CG, Morgan DJ, Sherman LA, Higgins AD, Pardoll DM, Adler AJ. CD4+ T cells pass through an effector phase during the process of in vivo tolerance induction. Journal of Immunology (Baltimore, Md. : 1950). 170: 3945-53. PMID 12682221 DOI: 10.4049/Jimmunol.170.8.3945  0.658
2001 Mirshahidi S, Huang C, Sadegh-Nasseri S. Anergy in peripheral memory CD4+ T cells induced by low avidity engagement of T cell receptor Journal of Experimental Medicine. 194: 719-731. PMID 11560989 DOI: 10.1084/Jem.194.6.719  0.502
2000 Adler AJ, Huang CT, Yochum GS, Marsh DW, Pardoll DM. In vivo CD4+ T cell tolerance induction versus priming is independent of the rate and number of cell divisions. Journal of Immunology (Baltimore, Md. : 1950). 164: 649-55. PMID 10623806 DOI: 10.4049/Jimmunol.164.2.649  0.657
Show low-probability matches.